Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px
Organisation › Details

BB100 LLC

BB100 is a fully owned subsidiary of Bravos Biosciences, LLC. Paul G. Ambrose, Pharm.D., F.I.D.S.A., currently serves as president of the Institute for Clinical Pharmacodynamics (ICPD, Schenectady, NY). Both Bravos Biosciences and ICPD are cofounded by Drs. Ambrose, Sujata M. Bhavnani and Christopher M. Rubino. The team’s areas of scientific inquiry primarily involve anti-infective translational science, with the goal of improving patient care through the application of pharmacokinetic-pharmacodynamic (PK-PD) principles. Dr. Ambrose has held academic appointments at the University of Oxford and the University at Buffalo as well as past industry positions including at Bristol Myers Squibb. Dr. Ambrose holds a Pharm.D. from the University of the Pacific and completed a Post-Doctoral Fellowship in infectious diseases at Hartford Hospital. *

 

Period Start 2018-04-04 existent
  Group Bravos Biosciences (Group)
Products Industry BIOTECH
  Industry 2 ASN200 (Bravos Bioscience / Arsanis)
     
  City n. a. 
    Address record changed: 2018-05-19
     
Basic data Employees n. a.
     
    * Document for �About Section�: Arsanis, Inc.. (4/4/18). "Press Release: Arsanis Out-Licenses Preclinical Stage E. coli Monoclonal Antibodies". Waltham, MA & Vienna.
     
   
Record changed: 2018-10-31

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for Bravos Biosciences (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px




» top